Vascular endothelial growth factor gene and protein: Strong expression in thyroiditis and thyroid carcinoma

Journal of Endocrinology

Volumn 161, Issue 1, 1999, Pages 41-49

  Klein, M ^a   Picard, E ^a   Vignaud, J M ^a   Marie, B ^a   Bresler, L ^a   Toussaint, B ^a   Weryha, G ^a   Duprez, A ^a   Leclere J ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; METASTASIS; METASTASIS POTENTIAL; MITOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CARCINOMA; THYROIDITIS;

EID: 0032937927     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1610041     Document Type: Article

References (34)

1. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N & King GL 1994 Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New England Journal of Medicine 331 1480-1487.
2. Berse B, Brown LF, Van de Water L, Dvorak HF & Senger DR 1992 Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Molecular Biology of the Cell 3 211-220.
3. Brown LF, Harrist TJ, Yeo KT, Stahle BM, Jackman RW, Berse B, Tognazzi K, Dvorak HF & Detmar M 1995a Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. Journal of Investigative Dermatology 104 744-749.
4. Brown LF, Olbricht SM, Berse B, Jackman RW, Matsueda G, Tognazzi KA, Manseau EJ, Dvorak HF & Van de Water L 1995b Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. Journal of Immunology 154 2801-2807.
5. Brown LF, Detmar M, Claffey K, Nagy JA, Feng A, Dvorak AM & Dvorak HF 1997 Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. In Regulation of Angiogenesis, pp 233-269. Eds ID Goldberg & EM Rosen. Basel, Boston, Berlin: Birkhäuser.
6. Cox KH, Deleon DV, Angerer LH & Angerer RC 1984 Detection of mRNAs in sea urchin embryo by in situ hybridization using asymmetric RNA probes. Developmental Biology 101 485-502.
7. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N & Williams LT 1992 The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255 989-991.
8. Dvorak HF, Detmar M, Claffey KP, Nagy JA, Van De Water L & Senger DR 1995 Vascular permeability factor/vascular endothelial growth factor: an important mediator ot angiogenesis in malignancy and inflammation. International Archives of Allergy and Immunology 107 233-235.
9. Fava RA, Olsen NJ, Spencer GG, Yeo KT, Yeo TK, Berse B, Jackman RW, Senger DR, Dvorak HF & Brown LF 1994 Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. Journal of Experimental Medicine 180 341-346.
10. Ferrara N 1995 The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Research and Treatment 36 127-137.
11. Ferrara N & Davis-Smyth T 1997 The biology of vascular endothelial growth factor. Endocrine Reviews 18 4-25.
12. Ferrara N & Keyt B 1997 Vascular endothelial growth factor: basic biology and clinical implications. In Regulation of Angiogenesis, pp 209-232. Eds ID Goldberg & EM Rosen. Basel, Boston, Berlin: Birkhäuser.
13. Folkman J 1997 Angiogenesis and angiogenesis inhibition: an overview. In Regulation of Angiogenesis, pp 1-18. Eds ID Goldberg & EM Rosen. Basel, Boston, Berlin: Birkhäuser.
14. Freeman MR, Schneck FX, Gagnon ML, Corless C, Soker S, Niknejad K, Peoples GE & Klagsbrun M 1995 Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Research 55 4140-4145.
15. Iijima K, Yoshikawa N & Nakamura H 1996 Activation-induced expression of vascular permeability factor by human peripheral T cells: a non-radioisotopic semiquantitative reverse transcription-polymerase chain reaction assay. Journal of Immunological Methods 196 199-209.
16. Ito A, Hirota S, Mizuno H, Kawasaki Y, Takemura T, Nishiura T, Kanakura Y, Katayama Y, Nomura S & Kitamura Y 1995 Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cells: possible involvement in the development of edema in chronic inflammation. Pathology International 45 715-720.
17. Kamat BR, Brown LF, Manseau EJ, Senger DR & Dvorak HF 1995 Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. American Journal of Pathology 146 157-165.
18. Katoh R, Bray CE, Suzuki K, Komiyama A, Hemmi A, Kawaoi A, Oyama T, Sugai T & Sasou S 1995 Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1. Human Pathology 26 139-146.
19. Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM &Ferrara N 1994 Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. Journal of Immunology 152 4149-4156.
20. Kondo S, Asano M & Suzuki H 1993 Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody. Biochemical and Biophysical Research Communications 194 1234-1241.
21. Ku DD, Zaleski JK, Liu S & Brock TA 1993 Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. American Journal of Physiology 265 H586-H592.
22. Okayasu I, Saegusa M, Fujiwara M, Hara Y & Rose NR 1995 Enhanced cellular proliferative activity and cell death in chronic thyroiditis and thyroid papillary carcinoma. Journal of Cancer Research and Clinical Oncology 121 746-752.
23. Pekala P, Marlow M, Heuvelman D & Connolly D 1990 Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. Journal of Biological Chemistry 265 18051-18054.
24. Plate KH, Breier G, Weich H & Risau W 1992 Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo, Nature 359 845-848.
25. Plouet J &Bayard F 1994 Regulations of vasculatropin/vascular endothelial growth factor bioavailability. Hormone Research 42 14-19.
26. Sato K, Yamazaki K, Shizume K, Kanaji Y, Obara T, Ohsumi K, Demura H, Yamaguchi S & Shibuya M 1995 Stimulation by thyroid-stimulating hormone and Graves' immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo. Journal of Clinical Investigation 96 1295-1302.
27. Sato K, Miyakawa M, Onoda N, Demura H, Yamashita T. Miura M, Kasajima T, Yamazaki K & Obara T 1997 Increased concentration of vascular endothelial growth factor/vascular permeability factor in cyst fluid of enlarging and recurrent thyroid nodules. Journal of Clinical Endocrinology and Metabolism 82 1968-1973.
28. Senger DR, Van do Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW, Dvorak AM & Dvorak HF 1993 Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer and Metastasis Reviews 12 303-324.
29. Simon M, Gröne H-J, Jöhren O, Kullmer J, Plate KH, Risau W & Fuchs E 1995 Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. American Journal of Physiology 268 F240-F250.
30. Soh EY, Sobhi SA, Wong MG, Meng YG, Siperstein AE, Clark OH & Duh QY 1996 Thyroid-stimulating hormone promotes the secretion ot vascular endothelial growth factor in thyroid cancer cell lines. Surgery 120 944 947.
31. Soh EY, Duh QY, Sobhi SA, Young DM, Epstein HD, Wong MG, Garcia YK, Min YD, Grossman RF, Siperstein AE & Clark OH 1997 Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid. Journal of Clinical Endocrinology and Metabolism 82 3741-3747.
32. Vighetto G, Maglione D, Rambaldi M, Cerutti J, Romano A, Trapasso F, Fedele M, Ippolito P, Chiappetta G, Botti G, Fusco A & Persico, MG 1995 Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PIGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene 11 1569-1579.
33. Vignaud J-M, Marie B, Klein N, Plénat F, Pech M, Borrelly J, Martinet N, Duprez A & Martinet Y 1994 The role of platelet-derived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer. Cancer Research 54 5455-5463.
34. Wang JF, Milosveski V, Schramek C, Fong GH, Becks GP & Hill DJ 1998 Presence and possible role of vascular endothelial growth factor in thyroid cell growth and function. Journal of Endocrinology 157 5-12.